Kamada Ltd. has completed a successful GMP audit of its manufacturing facility in Beit Kama, Israel by the Israeli Ministry of Health (IMOH). The audit was performed as part of a routine evaluation of the company’s manufacturing process for its plasma-derived protein therapeutics. The audit concludes that Kamada complies with GMP requirements for the manufacture of medicinal products, the importation of medicinal products and the manufacture of active substances using biological processes....